Intuitive Surgical, Inc. $ISRG Shares Sold by Atika Capital Management LLC

Atika Capital Management LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 57,236 shares of the medical equipment provider’s stock after selling 2,364 shares during the quarter. Intuitive Surgical makes up 2.1% of Atika Capital Management LLC’s portfolio, making the stock its 15th biggest position. Atika Capital Management LLC’s holdings in Intuitive Surgical were worth $25,598,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Tobam lifted its holdings in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in shares of Intuitive Surgical during the second quarter valued at $27,000. Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical during the third quarter worth about $27,000. Caitlin John LLC acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $30,000. Finally, Guerra Advisors Inc acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.4%

Shares of NASDAQ:ISRG opened at $492.87 on Thursday. The company has a 50 day moving average of $516.79 and a 200-day moving average of $512.60. The firm has a market cap of $175.03 billion, a P/E ratio of 62.47, a P/E/G ratio of 3.75 and a beta of 1.66. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter last year, the business earned $2.21 earnings per share. The business’s revenue for the quarter was up 18.8% on a year-over-year basis. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Citi upgraded ISRG to Buy and set a $590 price target, calling out resilient med‑tech fundamentals — a clear near‑term catalyst that likely pushed buying interest. Read More.
• Positive Sentiment: Analyst coverage and commentary emphasize product momentum (da Vinci 5, Ion and SP platforms) and procedure growth, supporting revenue and recurring‑revenue visibility into 2026. Read More.
• Positive Sentiment: Intuitive closed the acquisition of regional da Vinci and Ion distribution businesses, consolidating distribution and potentially improving margin/recurring revenue capture. Read More.
• Neutral Sentiment: Seeking Alpha reiterated the company’s strong moat and solid Q4 results but flagged valuation (P/E ~63 vs. historical ~53) and recommended a Hold — this tempers upside for value‑oriented investors. Read More.
• Neutral Sentiment: MarketWatch noted ISRG outperformed peers on a strong trading day, reflecting today’s buying interest but not adding new fundamental news. Read More.
• Neutral Sentiment: MarketBeat’s roundup reiterates broad analyst support and a consensus target near $616, underpinning a constructive longer‑term view but noting mixed ratings (Buy/Hold). Read More.
• Negative Sentiment: Insider selling: multiple recent sales by senior executives (SVP Mark Brosius and EVP Myriam Curet) have been disclosed; while common for compensation/liquidity reasons, clustered insider sales can weigh on sentiment. Read More.

Insider Activity

In related news, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of the business’s stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the completion of the sale, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. This trade represents a 86.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 37,907 shares of company stock worth $19,997,187. 0.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms have issued reports on ISRG. The Goldman Sachs Group reissued a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Evercore cut their price target on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a report on Friday, January 23rd. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Finally, HSBC increased their price objective on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.